Stock Ratings / Health Care / MDAI / insiders

SRTS (41) DXR (47) SNWV (51) DAVI (47) ⌘ Pro Terminal →

Spectral AI Inc. (Class A) (MDAI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$1.53 -2.55% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.52

Spectral AI Inc. (Class A) (MDAI) carries a Roarable Rating of E (Strong Sell) with 16/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (16/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $49.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MDAI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Spectral AI Inc. (Class A) (NASDAQ: MDAI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 16/100 at a spot price of $1.53 (-2.55% 1D, market cap $49.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 4/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, MDAI ranks #1012 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MDAI compare to SRTS and DXR in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), MDAI carries a Roarable E (16/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DXR (Daxor Corporation) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $53.7M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MDAI?

▼

Per MDAI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001833498), Spectral AI Inc. (Class A) generated $19.6M in revenue (-33.6% YoY), -$7.6M in net income, and -$9.9M in free cash flow against $21.4M in total assets and $5.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.52 (-0.65%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (16/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-12.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-19% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MDAI)Realized 20D OHLCV Swing Band: ±8%

Deterministic 5-Pillar Attribution (16/100 Composite)

🔍 WHY MDAI SCORES 16/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+6/20 pts (38% of score)

20D Institutional Volume Accumulation (±8% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+4/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 45.4% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.56-3.2% Next Q

Q2 (-2Q)

Grade E$1.51+1.3% Next Q

Q3 (-1Q)

Grade E$1.53+0% Next Q

Current

Grade E$1.53-12.7% Hist 90D α

Trajectory: E (24) → E (16)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a MDAI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While MDAI currently carries a cautious 16/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.58) and Max Pain ($1.61) forces dealer call-delta covering toward $3.12.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MDAI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MDAI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 18%NO 82%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

MDAI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (MDAI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on MDAI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MDAI)

✓Walkthrough of MDAI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MDAI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -32.60%🛡️ HOLDING TREND SUPPORT

2026-11-03O $1.57H $1.57L $1.53C $1.53VOL 120.8K

RES: $1.81SUP: $1.41SMA50: $1.58SMA200: $1.70

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MDAI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MDAI Butterfly Map → + Track MDAI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -33.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MDAI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MDAI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MDAI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MDAI)

Health Care Rank #1012 of 1016 ⚔️ SRTS vs MDAI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MDAI vs. SRTS, DXR, SNWV, DAVI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Spectral AI Inc. (Class A) (MDAI) ranks #1012 by composite RQD confidence (16/100, grade E) and #749 by equity capitalization ($49.2M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. SNWV currently holds the highest overall quantitative score in the immediate peer group at 51/100 (D) compared with MDAI at 16/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MDAI ACTIVE Spectral AI Inc. (Class A)	E	16/100	—	45.4%	-35.0%	-2.55%	$49.2M	Benchmark Subject
SRTS Sensus Healthcare Inc.	D-	41/100	—	43.2%	-31.3%	-0.36%	$45.4M	/srts-vs-mdai →
DXR Daxor Corporation	D	47/100	—	—	—	+3.14%	$53.7M	/dxr-vs-mdai →
SNWV SANUWAVE Health Inc.	D	51/100	3.8x	77.1%	67.3%	-2.28%	$44.3M	/snwv-vs-mdai →
DAVI Davion Healthcare Plc	D	47/100	—	—	—	-37.55%	$42.0M	/davi-vs-mdai →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001833498

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Spectral AI Inc. (Class A) (MDAI) reported GAAP revenue of $19.6M (-33.6% vs. FY2024 revenue of $29.6M , and +8.8% cumulative change since FY2023) , GAAP net income of -$7.6M, operating cash flow of -$9.9M, and free cash flow of -$9.9M (-7.8% YoY). On the balance sheet, MDAI closed FY2025 with $21.4M in total assets against $5.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$19.6M	-$7.6M	-$9.9M	-$9.9M	$21.4M	$5.5M
FY2024 (FY)	2024-12-31	$29.6M	-$15.2M	-$9.2M	-$9.2M	$12.1M	—
FY2023 (FY)	2023-12-31	$18.1M	-$20.9M	-$13.2M	-$13.2M	—	—

3. MDAI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does MDAI compare to SRTS and DXR in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for MDAI?

Where is MDAI trading relative to its 50-day, 200-day, and 52-week technical levels?

MDAI last traded at $1.53 (-2.55% on volume of 120,793 shares), positioning the stock -3.16% below its 50-day simple moving average ($1.58) and -10.00% below its 200-day simple moving average ($1.70). Across its 52-week range of $1.18 to $2.97, MDAI sits at the 19.6% percentile with a 14-day RSI of 46.1 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($1.41 to $1.65).

MDAI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are MDAI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies MDAI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: MDAI RQD Cockpit MDAI 12M Forecast MDAI Earnings & Move MDAI Dividends & DRIP MDAI Insiders & 13F MDAI Whale Options MDAI Profit Sankey MDAI News & Why

Sector Peer Dials

Compare →

SRTS D-

Sensus Healthcare Inc.

Davion Healthcare Plc

47 /100

XTNT C

Xtant Medical Holdings Inc.

MDAI Core Snapshot

Market Cap $49.2M

Trailing / Fwd P/E — / —

Gross Profit Margin 45.4%

Return on Capital (ROIC) -35.0%

Free Cash Flow Yield -19.63%

12M Base Price Target $1.24

FREE TRADER TOOLS

Own MDAI Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With MDAI → 🏆 Trade MDAI in $100K Prop Arena →

MDAI Wire

Why It Moved →

Direct Company Event Yahoo! Finance Canada • 19h ago

Spectral AI, Inc. (MDAIW) Stock Price, News, Quote & History

Direct Company Event Yahoo Finance UK • 22h ago

Spectral AI, Inc. (MDAI) Seasonal returns chart

Direct Company Event https://www.dars.gov.et/ • 1d ago

Spectral AI (MDAI) Slips 2.55% to $1.53 as Shares Test Lower End of Recent Range - Negative Gamma

Peer / Ecosystem Wire TradingKey • 1d ago

Most Active Stocks Today: U.S. Market

Peer / Ecosystem Wire Yahoo! Finance Canada • 1d ago

QScreen AI Inc. (QAI.CN) Seasonal Returns Chart - Yahoo Finance

ROARABLE RATING BRIEF • RQD 16/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

MDAI — Spectral AI Inc. (Class A): What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:46:53Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, MDAI scores 17 out of 100, graded E, with the verdict "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are: Fundamental Cash Engine at 0/20 (ROIC -35%; FCF yield -19.63%); Whale 13F Flow at 6/20 (institutional accumulation and options positioning); Insider Conviction at 3/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 4/20 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet at 4/20 (Altman Z 0.2; Piotroski F 2/9; Debt/Equity 0.5). The cash-engine pillar is the weakest, meaning the business is not currently generating returns or free cash flow that would support the equity value at the current price of 1.57. The forensic pillar reinforces this concern through a low Altman Z-Score and weak Piotroski reading. The modest institutional and insider scores indicate limited supporting ownership signals. For a prospective investor, the upside case would depend on a credible turnaround in cash generation, while the valuation tradeoff is that the stock trades at a low absolute price with a $50.5M market cap against negative margins and cash burn. The rating frames this as a high-risk profile rather than an analytical endorsement.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$19.6M	$-8.6M	$-7.6M	N/A	$-9.9M	$15.4M	$5.5M
FY 2024	$29.6M	$-6.6M	$-15.2M	N/A	$-9.2M	$5.2M	N/A
FY 2023	$18.1M	$-13.0M	$-20.9M	N/A	$-13.2M	N/A	N/A

Per the SEC financials, revenue declined from $29.6M in FY 2024 to $19.6M in FY 2025, while operating losses narrowed from $-13.0M in FY 2023 to $-8.6M in FY 2025. Per market data, operating margin is -43.8% and net margin is -38.5%, with ROIC at -35%. The Altman Z-Score is 0.2 and the Piotroski F-Score is 2/9, both per the Roarable RQD rating, indicating financial distress signals. Cash of $15.4M against debt of $5.5M is reported for FY 2025, with a Debt/Equity ratio of 0.5 per the RQD rating.

Recent Catalysts & News Wire Analysis

Six news items reference MDAI in the recent news data. Four are marked YELLOW and are market wire items: a Yahoo! Finance Canada report, a Yahoo Finance UK seasonal returns chart, a report on the stock slipping 2.55% to $1.53 while testing the lower end of its recent range (tagged "Negative Gamma"), and a TradingKey most-active-stocks listing. A Yahoo! Finance Canada seasonal chart for a related QScreen entity is also listed. One item is marked GREEN and is classified as a CATALYST: a TradingKey top U.S. stock gainers listing. The news data contains no company-issued announcements, earnings details, or contract disclosures. The butterfly supply-chain graph reports no supply chain links and no proprietary signals.

Open Questions

What products and customers generate the $19.6M in FY 2025 revenue, and what drove the decline from $29.6M in FY 2024?
What is the company's path to positive free cash flow given FCF of $-9.9M in FY 2025 and a FCF yield of -19.63%?
What is the debt structure and maturity schedule behind the $5.5M debt figure, and how does it interact with the $15.4M cash balance?
Who are the institutional and insider holders, since the holders data is not provided?
What are the EPS and valuation multiples, which are absent from the source data?

MDAI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Spectral AI Inc. (Class A) (MDAI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to MDAI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 19h ago

Spectral AI, Inc. (MDAIW) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 22h ago

Spectral AI, Inc. (MDAI) Seasonal returns chart

Yahoo Finance UK report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago

Spectral AI (MDAI) Slips 2.55% to $1.53 as Shares Test Lower End of Recent Range - Negative Gamma

https://www.dars.gov.et/ report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 1d ago

Most Active Stocks Today: U.S. Market

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

QScreen AI Inc. (QAI.CN) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST TradingKey • 1d ago

Top U.S. Stock Gainers: Biggest Price Increases

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 1d ago

Top U.S. Stock Losers: Biggest Price Declines

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo • 5d ago

Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call

DALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment d

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MDAI Bull vs. Bear Conversation Board — What's Your Call at $1.53?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MDAI 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.38 (-12.1%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is MDAI (E • RQD 17/100) a Buy at $1.57?

Welcome to the MDAI (Spectral AI Inc. (Class A)) Roar Pit. Current RQD Composite is 17/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.30 (-17.2%)

Spot @ $1.57

Pump the brakes on MDAI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on MDAI, but look at what you are paying: current EV/EBITDA multiples with 45.4% gross margins. Unless Spectral AI Inc. (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.88 (+19.7%)

Spot @ $1.57

MDAI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on MDAI, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $1.57 (52-wk range $1.18 - $2.97), any beat on forward guidance forces shorts and underweight funds to chase.